These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18810765)

  • 1. Crohn's disease--defect in innate defence.
    Gersemann M; Wehkamp J; Fellermann K; Stange EF
    World J Gastroenterol; 2008 Sep; 14(36):5499-503. PubMed ID: 18810765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From intestinal stem cells to inflammatory bowel diseases.
    Gersemann M; Stange EF; Wehkamp J
    World J Gastroenterol; 2011 Jul; 17(27):3198-203. PubMed ID: 21912468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paneth's disease.
    Wehkamp J; Stange EF
    J Crohns Colitis; 2010 Nov; 4(5):523-31. PubMed ID: 21122555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defensin-immunology in inflammatory bowel disease.
    Wehkamp J; Stange EF; Fellermann K
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S137-44. PubMed ID: 20117337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective paneth cell-mediated host defense in pediatric ileal Crohn's disease.
    Perminow G; Beisner J; Koslowski M; Lyckander LG; Stange E; Vatn MH; Wehkamp J
    Am J Gastroenterol; 2010 Feb; 105(2):452-9. PubMed ID: 19904243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal alpha-defensin expression in pediatric inflammatory bowel disease.
    Zilbauer M; Jenke A; Wenzel G; Goedde D; Postberg J; Phillips AD; Lucas M; Noble-Jamieson G; Torrente F; Salvestrini C; Heuschkel R; Wirth S
    Inflamm Bowel Dis; 2011 Oct; 17(10):2076-86. PubMed ID: 21910169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression.
    Wehkamp J; Harder J; Weichenthal M; Schwab M; Schäffeler E; Schlee M; Herrlinger KR; Stallmach A; Noack F; Fritz P; Schröder JM; Bevins CL; Fellermann K; Stange EF
    Gut; 2004 Nov; 53(11):1658-64. PubMed ID: 15479689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced Paneth cell alpha-defensins in ileal Crohn's disease.
    Wehkamp J; Salzman NH; Porter E; Nuding S; Weichenthal M; Petras RE; Shen B; Schaeffeler E; Schwab M; Linzmeier R; Feathers RW; Chu H; Lima H; Fellermann K; Ganz T; Stange EF; Bevins CL
    Proc Natl Acad Sci U S A; 2005 Dec; 102(50):18129-34. PubMed ID: 16330776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paneth cell function--implications in pediatric Crohn disease.
    Beisner J; Stange EF; Wehkamp J
    Gut Microbes; 2011; 2(1):47-51. PubMed ID: 21637018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crohn's disease-derived monocytes fail to induce Paneth cell defensins.
    Courth LF; Ostaff MJ; Mailänder-Sánchez D; Malek NP; Stange EF; Wehkamp J
    Proc Natl Acad Sci U S A; 2015 Nov; 112(45):14000-5. PubMed ID: 26512113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4.
    Wehkamp J; Wang G; Kübler I; Nuding S; Gregorieff A; Schnabel A; Kays RJ; Fellermann K; Burk O; Schwab M; Clevers H; Bevins CL; Stange EF
    J Immunol; 2007 Sep; 179(5):3109-18. PubMed ID: 17709525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease.
    Wehkamp J; Schmid M; Fellermann K; Stange EF
    J Leukoc Biol; 2005 Apr; 77(4):460-5. PubMed ID: 15618294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic inflammatory bowel diseases (IBD): novel pathophysiological concepts and their clinical relevance].
    Stange EF; Schmid M; Fellermann K; Wehkamp J
    Praxis (Bern 1994); 2005 Sep; 94(37):1429-32. PubMed ID: 16193905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate immune dysfunction in inflammatory bowel disease.
    Gersemann M; Wehkamp J; Stange EF
    J Intern Med; 2012 May; 271(5):421-8. PubMed ID: 22324936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new look at Crohn's disease: breakdown of the mucosal antibacterial defense.
    Wehkamp J; Stange EF
    Ann N Y Acad Sci; 2006 Aug; 1072():321-31. PubMed ID: 17057212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defensins and inflammation: the role of defensins in inflammatory bowel disease.
    Ramasundara M; Leach ST; Lemberg DA; Day AS
    J Gastroenterol Hepatol; 2009 Feb; 24(2):202-8. PubMed ID: 19215333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paneth cells and the innate immune response.
    Wehkamp J; Stange EF
    Curr Opin Gastroenterol; 2006 Nov; 22(6):644-50. PubMed ID: 17053443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory bowel disease: an impaired barrier disease.
    Jäger S; Stange EF; Wehkamp J
    Langenbecks Arch Surg; 2013 Jan; 398(1):1-12. PubMed ID: 23160753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa.
    Salzman NH; Underwood MA; Bevins CL
    Semin Immunol; 2007 Apr; 19(2):70-83. PubMed ID: 17485224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate immune functions of α-defensins in the small intestine.
    Bevins CL
    Dig Dis; 2013; 31(3-4):299-304. PubMed ID: 24246978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.